The over expression of Her-2 and lack of ER expression by the tumours of the patients aged below 55 years in our study might explain the high mortality rate reported earlier [1] among these patients, since such tumours often become resistant to adjuvant and hormone therapies. Here, ERBB2 is linked to neoplasm.